GrafTech Reports Fourth Quarter and Full Year 2023 Results
- None.
- Net loss of $217 million in Q4 2023, with adjusted EBITDA of negative $22 million
- Reduction in net sales by 45% in Q4 2023 compared to Q4 2022
- Significant decline in production volume and sales volume in 2023 compared to the prior year
- Anticipated weak demand for graphite electrodes in the near term
- Challenging pricing dynamics in most regions impacting the company's commercial opportunities
- Year-over-year decline in cash cost of goods sold per MT expected in 2024
Insights
The reported net loss of $217 million and a year-over-year sales decline of 52% for GrafTech International Ltd. indicates a significant downturn in the company's financial performance. This is primarily attributed to soft industry demand and operational challenges, such as the temporary suspension of operations in Mexico. The goodwill impairment charge of $171 million and inventory valuation adjustments suggest substantial non-cash impacts affecting the company's balance sheet. Investors should consider the likelihood of continued volatility in the company's earnings and the potential for further impairment charges in the future.
However, the focus on managing working capital and the resulting positive free cash flow, despite a net loss, shows the company's ability to maintain liquidity. The cost rationalization plan, aiming for annualized cost savings of approximately $25 million, could improve margins over the long term. Still, the one-time costs associated with these changes, estimated at $5 million, will impact short-term financials. The reduction in production capacity by 12% aligns with current demand but may limit revenue potential if demand unexpectedly increases.
The persistent softness in the commercial environment and weak graphite electrode demand have broader implications for the steel industry and related suppliers. GrafTech's shift in sales from long-term agreements to short-term and spot sales reflects a more uncertain and competitive market landscape, which could pressure prices and margins further. The company's strategic response to reduce overhead and production in line with demand is a common approach in industries facing cyclical downturns.
Despite the current challenges, the outlook for graphite electrodes may improve with the anticipated growth in electric arc furnace steelmaking, which is more environmentally friendly compared to traditional methods. GrafTech's vertical integration into petroleum needle coke could provide a competitive advantage as demand for this raw material increases due to its use in lithium-ion batteries for electric vehicles. This suggests potential for long-term growth, despite the near-term headwinds.
The global economic uncertainty affecting steel production directly impacts GrafTech's business, as evidenced by the reported weak demand for graphite electrodes. The company's financial results reflect the broader macroeconomic trends, including reduced industrial activity and cautious capital expenditure by customers. The reported decline in net sales and the shift from long-term agreements to short-term sales indicate that customers are also facing uncertainty and are less willing to commit to long-term contracts.
Cost rationalization efforts are a response to these economic pressures, but they also reflect a strategic decision to preserve cash flow and maintain financial stability. The anticipated modest year-over-year improvement in sales volume for 2024 suggests that the company expects some stabilization or slight recovery in market conditions. However, the overall economic outlook remains a critical factor for GrafTech's performance, with potential risks including further economic downturns or slower-than-expected industry decarbonization efforts.
Fourth Quarter Results and 2024 Outlook Reflect Persistent Softness in the Commercial Environment
GrafTech Announces Cost Rationalization and Footprint Optimization Plan
Fourth Quarter 2023 Highlights
-
Net loss of
, or$217 million per share(1)$0.85 -
Includes a goodwill impairment charge of
and a lower of cost or market ("LCM") inventory valuation adjustment of$171 million $12 million -
Adjusted EBITDA(2) of negative
, including the LCM inventory valuation adjustment$22 million - Sales volume of 24 thousand metric tons ("MT")
- Production volume of 24 thousand MT
-
Net cash provided by operating activities of
$9 million -
Adjusted free cash flow(2) of
$4 million
Full Year 2023 Highlights
-
Net loss of
, or$255 million per share(1)$0.99 -
Adjusted EBITDA(2) of
$20 million - Sales volume of 92 thousand MT
- Production volume of 88 thousand MT
-
Net cash provided by operating activities of
$77 million -
Adjusted free cash flow(2) of
$50 million
CEO Comments
"2023 was a challenging year for our business, marked by soft industry demand, the residual impact of the temporary suspension of our operations in
"As we enter 2024, we are experiencing ongoing softness in the commercial environment, with graphite electrode demand weak and pricing continuing to be pressured," said Mr. Flanagan. "In response, we are adding to the steps taken in 2023 by taking a number of further actions to reduce costs and optimize our manufacturing footprint. These include indefinitely suspending the majority of our production processes at our
Cost Rationalization and Footprint Optimization Plan
In response to persistent softness in the commercial environment, the Company today announced a set of initiatives designed to reduce our cost structure and optimize our manufacturing footprint while, at the same time, preserving our ability to deliver excellent customer service and to capitalize on long-term growth opportunities for our Company. Key elements include the following:
-
Indefinitely suspending production activities at our
St. Marys, Pennsylvania facility, with the exception of graphite electrode and pin machining, as well as indefinitely idling certain assets within our remaining graphite electrode manufacturing footprint. - Reducing the Company's overhead structure and expenses.
- Operating our remaining graphite electrode production facilities at reduced levels, as needed, to align production with our view on market demand.
These initiatives, most notably the indefinite suspension of production at
As of December 31, 2023, our stated graphite electrode production capacity was approximately 202 thousand MT(3)(4). As a result of indefinitely idling certain assets, beginning in 2024, our stated production capacity will be approximately 178 thousand MT(3)(4), a reduction of
Further, during 2024, we will continue to operate these facilities at reduced levels, as needed, to align production with our view on electrode demand. In addition to being a key component of the incremental actions we are taking in response to weak market conditions, this will also support our efforts to further reduce our inventory levels and manage capital expenditures in 2024. Specific to capital expenditures, for 2024 we anticipate spending to be in the range of
Fourth Quarter and Full Year 2023 Financial Performance |
||||||||||||||
(dollars in thousands, except per share amounts) |
|
|
Year Ended December 31, |
|||||||||||
|
|
|||||||||||||
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
|
2023 |
|
|
2022 |
||||||
Net sales |
$ |
137,145 |
|
$ |
158,992 |
|
$ |
247,519 |
|
$ |
620,500 |
|
$ |
1,281,250 |
Net (loss) income |
$ |
(217,409 |
) |
$ |
(22,621 |
) |
$ |
50,331 |
|
$ |
(255,250 |
) |
$ |
382,962 |
(Loss) earnings per share(1) |
$ |
(0.85 |
) |
$ |
(0.09 |
) |
$ |
0.20 |
|
$ |
(0.99 |
) |
$ |
1.48 |
Net cash provided by operating activities |
$ |
9,292 |
|
$ |
51,495 |
|
$ |
50,023 |
|
$ |
76,561 |
|
$ |
324,628 |
|
|
|
|
|
|
|
||||||||
Adjusted net (loss) income(2) |
$ |
(68,569 |
) |
$ |
(20,866 |
) |
$ |
44,761 |
|
$ |
(100,752 |
) |
$ |
379,666 |
Adjusted (loss) earnings per share(1)(2) |
$ |
(0.27 |
) |
$ |
(0.08 |
) |
$ |
0.17 |
|
$ |
(0.39 |
) |
$ |
1.47 |
Adjusted EBITDA(2) |
$ |
(21,572 |
) |
$ |
919 |
|
$ |
80,101 |
|
$ |
20,484 |
|
$ |
536,464 |
Adjusted free cash flow(2) |
$ |
3,539 |
|
$ |
42,997 |
|
$ |
25,800 |
|
$ |
49,974 |
|
$ |
259,329 |
Net sales for the fourth quarter of 2023 were
Net loss for the fourth quarter of 2023 was
Adjusted EBITDA(2) was a negative
In the fourth quarter of 2023, net cash provided by operating activities was
For the year ended December 31, 2023, net sales decreased
Net loss for 2023 was
Net cash provided by operating activities for 2023 was
Operational and Commercial Update |
|||||||||||
Key Operating Metrics |
|
|
|
|
Year Ended December 31, |
||||||
|
|
|
|
|
|||||||
(in thousands, except percentages) |
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
2022 |
|
|||
Sales volume (MT) |
24.1 |
|
24.2 |
|
27.8 |
|
|
91.6 |
|
149.1 |
|
Production volume (MT)(5) |
24.4 |
|
22.7 |
|
29.4 |
|
|
88.1 |
|
157.1 |
|
Total production capacity (MT)(3)(6) |
59.0 |
|
55.0 |
|
59.0 |
|
|
230.0 |
|
230.0 |
|
Total capacity utilization(6)(7) |
41 |
% |
41 |
% |
50 |
% |
|
38 |
% |
68 |
% |
Production capacity excluding |
52.0 |
|
48.0 |
|
52.0 |
|
|
202.0 |
|
202.0 |
|
Capacity utilization excluding |
47 |
% |
47 |
% |
57 |
% |
|
44 |
% |
78 |
% |
Sales volume for the fourth quarter of 2023 was 24.1 thousand MT, a decrease of
For the fourth quarter of 2023, the weighted-average realized price for our LTA volume was approximately
Production volume for the fourth quarter of 2023 was 24.4 thousand MT, a decrease of
For the year ended December 31, 2023, sales volume decreased
The table of estimated shipments of graphite electrodes under existing LTAs is as follows, reflecting our current expectations for the full year 2024:
|
|
2024 |
Estimated LTA volume (in thousands of MT) |
|
13 - 16 |
Estimated LTA revenue (in millions) |
|
|
Capital Structure and Liquidity
As of December 31, 2023, we had liquidity of
Outlook
As we enter 2024, we expect demand for graphite electrodes in the near term will remain weak, reflecting persistent softness in the commercial environment as steel industry production remains constrained by global economic uncertainty. However, we anticipate a modest year-over-year improvement in our sales volume for 2024, most notably in the first quarter of 2024, as the first quarter of 2023 was significantly impacted by the temporary suspension of our
Reflecting industry-wide softness in graphite electrode demand, challenging pricing dynamics have persisted in most regions. As a result, we are being selective in the commercial opportunities we choose to pursue. In addition, we are taking the previously described actions to further reduce our cost structure and optimize our manufacturing footprint. These actions, combined with the benefit of reduced market pricing for certain raw materials and energy, as well as the anticipated improvement in our sales and production volume levels, are expected to result in a significant year-over-year decline in our cash cost of goods sold per MT.
Longer term, we remain confident that the steel industry’s accelerating efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We also anticipate the demand for petroleum needle coke, the key raw material we use to produce graphite electrodes, to accelerate driven by its utilization in producing synthetic graphite for use in lithium-ion batteries for the growing electric vehicle market. We believe that the near-term actions we are taking, supported by an industry-leading position and our sustainable competitive advantages, including our substantial vertical integration into petroleum needle coke via our Seadrift facility, will optimally position GrafTech to benefit from that long-term growth.
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings conference call being held on February 14, 2024 at 10:00 a.m. (EST). The webcast and accompanying slide presentation will be available on our investor relations website at: http://ir.graftech.com. The conference call dial-in number is +1 (888) 886-7786 toll-free in
About GrafTech
GrafTech International Ltd. is a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. The Company has a competitive portfolio of low-cost, ultra-high power graphite electrode manufacturing facilities, with some of the highest capacity facilities in the world. We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, our key raw material for graphite electrode manufacturing. This unique position provides us with competitive advantages in product quality and cost.
________________________
(1) |
(Loss) earnings per share represents diluted (loss) earnings per share. Adjusted (loss) earnings per share represents diluted adjusted (loss) earnings per share. |
|
(2) |
A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
|
(3) |
Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary. |
|
(4) |
Includes graphite electrode facilities in Calais, |
|
(5) |
Production volume reflects graphite electrodes we produced during the period. |
|
(6) |
Includes graphite electrode facilities in Calais, |
|
(7) |
Capacity utilization reflects production volume as a percentage of production capacity. |
|
(8) |
Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs. |
|
(9) |
Gross debt reflects the notional value of our outstanding debt and excludes unamortized debt discount and issuance costs. |
|
(10) |
A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents (December 31, 2023 gross debt of |
Cautionary Note Regarding Forward-Looking Statements
This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the
These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our most recent Annual Report on Form 10-K and other filings with the SEC. The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Except as required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Non‑GAAP Financial Measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow, adjusted free cash flow, net debt and cash cost of goods sold per MT are non-GAAP financial measures.
We define EBITDA, a non‑GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA, a non-GAAP financial measure, as EBITDA adjusted by any pension and other post-employment benefit ("OPEB") plan expenses or benefits, adjustments for public offerings and related expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt service capabilities.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses or benefits relating to our pension and OPEB plans;
- adjusted EBITDA does not reflect public offerings and related expenses;
-
adjusted EBITDA does not reflect the non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar; - adjusted EBITDA does not reflect stock-based compensation expense;
- adjusted EBITDA does not reflect the non‑cash write‑off of fixed assets;
- adjusted EBITDA does not reflect related party payable - Tax Receivable Agreement adjustments;
- adjusted EBITDA does not reflect goodwill impairment charges; and
- other companies, including companies in our industry, may calculate EBITDA and adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
We define adjusted net (loss) income, a non‑GAAP financial measure, as net (loss) income, excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted (loss) earnings per share, a non‑GAAP financial measure, as adjusted net (loss) income divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net (loss) income and adjusted (loss) earnings per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
We define free cash flow, a non-GAAP financial measure, as net cash provided by operating activities less capital expenditures. We define adjusted free cash flow, a non-GAAP financial measure, as free cash flow adjusted by payments made or received from the settlement of interest rate swap contracts and payments of the Change in Control charges that were triggered as a result of the ownership of our largest stockholder falling below
We define net debt, a non-GAAP financial measure, as gross debt minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.
We define cash cost of goods sold per MT, a non-GAAP financial measure, as cost of goods sold less depreciation and amortization and less cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes, with this total divided by our sales volume measured in MT. We believe this is an important measure as it is used by our management and Board of Directors to evaluate our costs on a per MT basis.
In evaluating EBITDA, adjusted EBITDA, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of EBITDA, adjusted EBITDA, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider EBITDA, adjusted EBITDA, adjusted net (loss) income, adjusted (loss) earnings per share, free cash flow and adjusted free cash flow alongside other measures of financial performance and liquidity, including our net (loss) income, (loss) earnings per share and cash flow from operating activities, respectively, and other GAAP measures.
GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Dollars in thousands, except per share data) (Unaudited) |
|||||||
|
December 31,
|
|
December 31,
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
176,878 |
|
|
$ |
134,641 |
|
Accounts and notes receivable, net of allowance for doubtful accounts of |
|
101,387 |
|
|
|
145,574 |
|
Inventories |
|
330,146 |
|
|
|
447,741 |
|
Prepaid expenses and other current assets |
|
66,382 |
|
|
|
87,272 |
|
Total current assets |
|
674,793 |
|
|
|
815,228 |
|
Property, plant and equipment |
|
920,444 |
|
|
|
869,168 |
|
Less: accumulated depreciation |
|
398,330 |
|
|
|
350,022 |
|
Net property, plant and equipment |
|
522,114 |
|
|
|
519,146 |
|
Deferred income taxes |
|
31,542 |
|
|
|
11,960 |
|
Goodwill |
|
— |
|
|
|
171,117 |
|
Other assets |
|
60,440 |
|
|
|
86,727 |
|
Total assets |
$ |
1,288,889 |
|
|
$ |
1,604,178 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
83,268 |
|
|
$ |
103,156 |
|
Long-term debt, current maturities |
|
134 |
|
|
|
124 |
|
Accrued income and other taxes |
|
10,022 |
|
|
|
40,592 |
|
Other accrued liabilities |
|
91,702 |
|
|
|
89,349 |
|
Related party payable - Tax Receivable Agreement |
|
5,417 |
|
|
|
4,631 |
|
Total current liabilities |
|
190,543 |
|
|
|
237,852 |
|
Long-term debt |
|
925,511 |
|
|
|
921,803 |
|
Other long-term obligations |
|
55,645 |
|
|
|
50,822 |
|
Deferred income taxes |
|
33,206 |
|
|
|
45,065 |
|
Related party payable - Tax Receivable Agreement long-term |
|
5,737 |
|
|
|
10,921 |
|
Stockholders’ equity: |
|
|
|
||||
Preferred stock, par value |
|
— |
|
|
|
— |
|
Common stock, par value shares issued and outstanding as of December 31, 2023 and 256,597,342 as of December 31, 2022 |
|
2,568 |
|
|
|
2,566 |
|
Additional paid-in capital |
|
749,527 |
|
|
|
745,164 |
|
Accumulated other comprehensive loss |
|
(11,458 |
) |
|
|
(8,070 |
) |
Accumulated deficit |
|
(662,390 |
) |
|
|
(401,945 |
) |
Total stockholders’ equity |
|
78,247 |
|
|
|
337,715 |
|
Total liabilities and stockholders’ equity |
$ |
1,288,889 |
|
|
$ |
1,604,178 |
|
GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in thousands, except per share data) (Unaudited) |
|||||||||||||||
|
Three Months Ended December 31, |
|
Year Ended December 31, |
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net sales |
$ |
137,145 |
|
|
$ |
247,519 |
|
|
$ |
620,500 |
|
|
$ |
1,281,250 |
|
Cost of goods sold |
|
144,393 |
|
|
|
163,492 |
|
|
|
571,857 |
|
|
|
726,373 |
|
Lower of cost or market inventory valuation adjustment |
|
12,431 |
|
|
|
— |
|
|
|
12,431 |
|
|
|
— |
|
Gross (loss) profit |
|
(19,679 |
) |
|
|
84,027 |
|
|
|
36,212 |
|
|
|
554,877 |
|
Research and development |
|
1,837 |
|
|
|
1,024 |
|
|
|
5,520 |
|
|
|
3,641 |
|
Selling and administrative expenses |
|
15,079 |
|
|
|
19,115 |
|
|
|
74,012 |
|
|
|
76,977 |
|
Goodwill impairment charges |
|
171,117 |
|
|
|
— |
|
|
|
171,117 |
|
|
|
— |
|
Operating (loss) income |
|
(207,712 |
) |
|
|
63,888 |
|
|
|
(214,437 |
) |
|
|
474,259 |
|
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
3,418 |
|
|
|
(8,789 |
) |
|
|
4,679 |
|
|
|
(10,147 |
) |
Interest expense |
|
15,655 |
|
|
|
11,533 |
|
|
|
58,087 |
|
|
|
36,568 |
|
Interest income |
|
(1,681 |
) |
|
|
(2,283 |
) |
|
|
(3,439 |
) |
|
|
(4,480 |
) |
(Loss) income before (benefit) provision for income taxes |
|
(225,104 |
) |
|
|
63,427 |
|
|
|
(273,764 |
) |
|
|
452,318 |
|
(Benefit) provision for income taxes |
|
(7,695 |
) |
|
|
13,096 |
|
|
|
(18,514 |
) |
|
|
69,356 |
|
Net (loss) income |
$ |
(217,409 |
) |
|
$ |
50,331 |
|
|
$ |
(255,250 |
) |
|
$ |
382,962 |
|
|
|
|
|
|
|
|
|
||||||||
Basic (loss) income per common share: |
|
|
|
|
|
|
|
||||||||
Net (loss) income per share |
$ |
(0.85 |
) |
|
$ |
0.20 |
|
|
$ |
(0.99 |
) |
|
$ |
1.48 |
|
Weighted average common shares outstanding |
|
257,205,583 |
|
|
|
256,900,707 |
|
|
|
257,042,843 |
|
|
|
258,781,843 |
|
Diluted (loss) income per common share: |
|
|
|
|
|
|
|
||||||||
Net (loss) income per share |
$ |
(0.85 |
) |
|
$ |
0.20 |
|
|
$ |
(0.99 |
) |
|
$ |
1.48 |
|
Weighted average common shares outstanding |
|
257,205,583 |
|
|
|
256,902,385 |
|
|
|
257,042,843 |
|
|
|
258,791,228 |
|
GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) (Unaudited) |
|||||||||||||||
|
Three Months Ended December 31, |
|
Year Ended December 31, |
||||||||||||
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Cash flow from operating activities: |
|
|
|
|
|
|
|
||||||||
Net (loss) income |
$ |
(217,409 |
) |
|
$ |
50,331 |
|
|
$ |
(255,250 |
) |
|
$ |
382,962 |
|
Adjustments to reconcile net (loss) income to cash provided by operations: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
13,836 |
|
|
|
13,788 |
|
|
|
56,889 |
|
|
|
55,496 |
|
Deferred income tax (benefit) provision |
|
(17,826 |
) |
|
|
5,806 |
|
|
|
(28,123 |
) |
|
|
17,022 |
|
Non-cash stock-based compensation expense |
|
624 |
|
|
|
645 |
|
|
|
4,433 |
|
|
|
2,311 |
|
Non-cash interest (benefit) expense |
|
(1,463 |
) |
|
|
675 |
|
|
|
8,786 |
|
|
|
(2,428 |
) |
Goodwill impairment charges |
|
171,117 |
|
|
|
— |
|
|
|
171,117 |
|
|
|
— |
|
Lower of cost or market inventory valuation adjustment |
|
12,431 |
|
|
|
— |
|
|
|
12,431 |
|
|
|
— |
|
Other adjustments |
|
8,355 |
|
|
|
(8,253 |
) |
|
|
5,077 |
|
|
|
(8,023 |
) |
Net change in working capital* |
|
42,729 |
|
|
|
2,047 |
|
|
|
107,562 |
|
|
|
(99,575 |
) |
Change in related-party Tax Receivable Agreement |
|
233 |
|
|
|
— |
|
|
|
(4,398 |
) |
|
|
(3,828 |
) |
Change in long-term assets and liabilities |
|
(3,335 |
) |
|
|
(15,016 |
) |
|
|
(1,963 |
) |
|
|
(19,309 |
) |
Net cash provided by operating activities |
|
9,292 |
|
|
|
50,023 |
|
|
|
76,561 |
|
|
|
324,628 |
|
Cash flow from investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures |
|
(5,753 |
) |
|
|
(26,884 |
) |
|
|
(54,040 |
) |
|
|
(72,165 |
) |
Proceeds from the sale of assets |
|
— |
|
|
|
34 |
|
|
|
220 |
|
|
|
195 |
|
Net cash used in investing activities |
|
(5,753 |
) |
|
|
(26,850 |
) |
|
|
(53,820 |
) |
|
|
(71,970 |
) |
Cash flow from financing activities: |
|
|
|
|
|
|
|
||||||||
Interest rate swap settlements |
|
— |
|
|
|
2,661 |
|
|
|
27,453 |
|
|
|
6,423 |
|
Debt issuance and modification costs |
|
(19 |
) |
|
|
— |
|
|
|
(8,152 |
) |
|
|
(2,232 |
) |
Proceeds from the issuance of long-term debt, net of original issuance discount |
|
— |
|
|
|
— |
|
|
|
438,552 |
|
|
|
— |
|
Principal payments on long-term debt |
|
(133 |
) |
|
|
(124 |
) |
|
|
(433,841 |
) |
|
|
(110,124 |
) |
Repurchase of common stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(60,000 |
) |
Payments for taxes related to net share settlement of equity awards |
|
— |
|
|
|
— |
|
|
|
(129 |
) |
|
|
(230 |
) |
Proceeds from exercise of stock options |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
225 |
|
Dividends paid to non-related party |
|
— |
|
|
|
(1,927 |
) |
|
|
(3,854 |
) |
|
|
(7,770 |
) |
Dividends paid to related party |
|
— |
|
|
|
(640 |
) |
|
|
(1,280 |
) |
|
|
(2,559 |
) |
Principal payments under finance lease obligations |
|
(16 |
) |
|
|
— |
|
|
|
(36 |
) |
|
|
— |
|
Net cash (used in) provided by financing activities |
|
(168 |
) |
|
|
(30 |
) |
|
|
18,713 |
|
|
|
(176,267 |
) |
Net change in cash and cash equivalents |
|
3,371 |
|
|
|
23,143 |
|
|
|
41,454 |
|
|
|
76,391 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
700 |
|
|
|
2,104 |
|
|
|
783 |
|
|
|
736 |
|
Cash and cash equivalents at beginning of period |
|
172,807 |
|
|
|
109,394 |
|
|
|
134,641 |
|
|
|
57,514 |
|
Cash and cash equivalents at end of period |
$ |
176,878 |
|
|
$ |
134,641 |
|
|
$ |
176,878 |
|
|
$ |
134,641 |
|
|
|
|
|
|
|
|
|
||||||||
* Net change in working capital due to changes in the following components: |
|
|
|
|
|
|
|||||||||
Accounts and notes receivable, net |
$ |
(2,327 |
) |
|
$ |
38,278 |
|
|
$ |
45,680 |
|
|
$ |
60,507 |
|
Inventories |
|
38,538 |
|
|
|
(7,078 |
) |
|
|
107,796 |
|
|
|
(153,579 |
) |
Prepaid expenses and other current assets |
|
(1,622 |
) |
|
|
(1,097 |
) |
|
|
3,352 |
|
|
|
593 |
|
Income taxes payable |
|
4,158 |
|
|
|
5,197 |
|
|
|
(27,198 |
) |
|
|
(15,029 |
) |
Accounts payable and accruals |
|
19,515 |
|
|
|
(27,625 |
) |
|
|
(23,876 |
) |
|
|
7,748 |
|
Interest payable |
|
(15,533 |
) |
|
|
(5,628 |
) |
|
|
1,808 |
|
|
|
185 |
|
Net change in working capital |
$ |
42,729 |
|
|
$ |
2,047 |
|
|
$ |
107,562 |
|
|
$ |
(99,575 |
) |
NON-GAAP RECONCILIATIONS (Dollars in thousands, except per share and per MT data) (Unaudited)
The following tables reconcile our non-GAAP financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation of Net (Loss) Income to Adjusted Net (Loss) Income |
|
|
|||||||||||||
|
|
|
|
Year Ended
|
|||||||||||
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
|
2022 |
|
||||||
|
|
|
|
|
|
||||||||||
Net (loss) income |
$ |
(217,409 |
) |
$ |
(22,621 |
) |
$ |
50,331 |
|
$ |
(255,250 |
) |
$ |
382,962 |
|
|
|
|
|
|
|
||||||||||
Diluted (loss) income per common share: |
|
|
|
|
|
||||||||||
Net (loss) income per share |
$ |
(0.85 |
) |
$ |
(0.09 |
) |
$ |
0.20 |
|
$ |
(0.99 |
) |
$ |
1.48 |
|
Weighted average shares outstanding |
|
257,205,583 |
|
|
257,090,113 |
|
|
256,902,385 |
|
|
257,042,843 |
|
|
258,791,228 |
|
|
|
|
|
|
|
||||||||||
Adjustments, pre-tax: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
3,578 |
|
|
914 |
|
|
(8,993 |
) |
|
6,309 |
|
|
(7,355 |
) |
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
100 |
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
170 |
|
|
(287 |
) |
|
819 |
|
|
603 |
|
|
521 |
|
Stock-based compensation expense(4) |
|
624 |
|
|
1,628 |
|
|
645 |
|
|
4,433 |
|
|
2,311 |
|
Non-cash fixed asset write-off(5) |
|
— |
|
|
— |
|
|
1,068 |
|
|
— |
|
|
1,068 |
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
233 |
|
|
— |
|
|
97 |
|
|
249 |
|
|
(83 |
) |
Goodwill impairment charges(7) |
|
171,117 |
|
|
— |
|
|
— |
|
|
171,117 |
|
|
— |
|
Total non-GAAP adjustments pre-tax |
|
175,722 |
|
|
2,255 |
|
|
(6,364 |
) |
|
182,711 |
|
|
(3,438 |
) |
Income tax impact on non-GAAP adjustments(8) |
|
26,882 |
|
|
500 |
|
|
(794 |
) |
|
28,213 |
|
|
(142 |
) |
Adjusted net (loss) income |
$ |
(68,569 |
) |
$ |
(20,866 |
) |
$ |
44,761 |
|
$ |
(100,752 |
) |
$ |
379,666 |
|
Reconciliation of (Loss) Earnings Per Share to Adjusted (Loss) Earnings Per Share |
|
|
|||||||||||||
|
|
|
|
Year Ended
|
|||||||||||
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
|
2022 |
|
||||||
|
|
|
|
|
|
||||||||||
(Loss) Earnings per share |
$ |
(0.85 |
) |
$ |
(0.09 |
) |
$ |
0.20 |
|
$ |
(0.99 |
) |
$ |
1.48 |
|
Adjustments per share: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
0.01 |
|
|
— |
|
|
(0.04 |
) |
|
0.02 |
|
|
(0.03 |
) |
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Stock-based compensation expense(4) |
|
— |
|
|
0.01 |
|
|
— |
|
|
0.02 |
|
|
0.01 |
|
Non-cash fixed asset write-off(5) |
|
— |
|
|
— |
|
|
0.01 |
|
|
— |
|
|
0.01 |
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Goodwill impairment charges(7) |
|
0.67 |
|
|
— |
|
|
— |
|
|
0.67 |
|
|
— |
|
Total non-GAAP adjustments pre-tax per share |
|
0.68 |
|
|
0.01 |
|
|
(0.03 |
) |
|
0.71 |
|
|
(0.01 |
) |
Income tax impact on non-GAAP adjustments per share(8) |
|
0.10 |
|
|
— |
|
|
— |
|
|
0.11 |
|
|
— |
|
Adjusted (loss) earnings per share |
$ |
(0.27 |
) |
$ |
(0.08 |
) |
$ |
0.17 |
|
$ |
(0.39 |
) |
$ |
1.47 |
|
Reconciliation of Net (Loss) Income to EBITDA and Adjusted EBITDA |
|
|
|||||||||||||
|
|
|
|
Year Ended December 31, |
|||||||||||
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
|
2022 |
|
||||||
|
|
|
|
|
|
||||||||||
Net (loss) income |
$ |
(217,409 |
) |
$ |
(22,621 |
) |
$ |
50,331 |
|
$ |
(255,250 |
) |
$ |
382,962 |
|
Add: |
|
|
|
|
|
||||||||||
Depreciation and amortization |
|
13,836 |
|
|
16,954 |
|
|
13,788 |
|
|
56,889 |
|
|
55,496 |
|
Interest expense |
|
15,655 |
|
|
15,719 |
|
|
11,533 |
|
|
58,087 |
|
|
36,568 |
|
Interest income |
|
(1,681 |
) |
|
(1,144 |
) |
|
(2,283 |
) |
|
(3,439 |
) |
|
(4,480 |
) |
Income taxes |
|
(7,695 |
) |
|
(10,244 |
) |
|
13,096 |
|
|
(18,514 |
) |
|
69,356 |
|
EBITDA |
|
(197,294 |
) |
|
(1,336 |
) |
|
86,465 |
|
|
(162,227 |
) |
|
539,902 |
|
Adjustments: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (benefits)(1) |
|
3,578 |
|
|
914 |
|
|
(8,993 |
) |
|
6,309 |
|
|
(7,355 |
) |
Public offerings and related expenses(2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
100 |
|
Non-cash losses (gains) on foreign currency remeasurement(3) |
|
170 |
|
|
(287 |
) |
|
819 |
|
|
603 |
|
|
521 |
|
Stock-based compensation expense(4) |
|
624 |
|
|
1,628 |
|
|
645 |
|
|
4,433 |
|
|
2,311 |
|
Non-cash fixed asset write-off(5) |
|
— |
|
|
— |
|
|
1,068 |
|
|
— |
|
|
1,068 |
|
Related party payable - Tax Receivable Agreement adjustment(6) |
|
233 |
|
|
— |
|
|
97 |
|
|
249 |
|
|
(83 |
) |
Goodwill impairment charges(7) |
|
171,117 |
|
|
— |
|
|
— |
|
|
171,117 |
|
|
— |
|
Adjusted EBITDA |
$ |
(21,572 |
) |
$ |
919 |
|
$ |
80,101 |
|
$ |
20,484 |
|
$ |
536,464 |
|
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow and Adjusted Free Cash Flow |
|||||||||||||||
|
|
|
|
Year Ended December 31, |
|||||||||||
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
|
2022 |
|
||||||
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities |
$ |
9,292 |
|
$ |
51,495 |
|
$ |
50,023 |
|
$ |
76,561 |
|
$ |
324,628 |
|
Capital expenditures |
|
(5,753 |
) |
|
(8,498 |
) |
|
(26,884 |
) |
|
(54,040 |
) |
|
(72,165 |
) |
Free cash flow |
|
3,539 |
|
|
42,997 |
|
|
23,139 |
|
|
22,521 |
|
|
252,463 |
|
|
|
|
|
|
|
||||||||||
Interest rate swap settlements(9)(10) |
|
— |
|
|
— |
|
|
2,661 |
|
|
27,453 |
|
|
6,423 |
|
Change in Control payment(11) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
443 |
|
Adjusted free cash flow |
$ |
3,539 |
|
$ |
42,997 |
|
$ |
25,800 |
|
$ |
49,974 |
|
$ |
259,329 |
|
Reconciliation of Cost of Goods Sold to Cash Cost of Goods Sold per MT |
||||||||||||||
|
|
|
|
Year Ended December 31, |
||||||||||
|
Q4 2023 |
Q3 2023 |
Q4 2022 |
|
2023 |
|
2022 |
|||||||
|
|
|
|
|
|
|||||||||
Cost of goods sold |
$ |
144,393 |
$ |
157,603 |
$ |
163,492 |
$ |
571,857 |
$ |
726,373 |
||||
Less: |
|
|
|
|
|
|||||||||
Depreciation and amortization(12) |
|
12,163 |
|
15,291 |
|
12,078 |
|
50,124 |
|
48,680 |
||||
Cost of goods sold - by-products and other(13) |
|
780 |
|
430 |
|
7,716 |
|
14,500 |
|
41,611 |
||||
Cash cost of goods sold |
|
131,450 |
|
141,882 |
|
143,698 |
|
507,233 |
|
636,082 |
||||
Sales volume (in thousands of MT) |
|
24.1 |
|
24.2 |
|
27.8 |
|
91.6 |
|
149.1 |
||||
Cash cost of goods sold per MT |
$ |
5,454 |
$ |
5,863 |
$ |
5,169 |
$ |
5,537 |
$ |
4,266 |
(1) |
Net periodic benefit cost (credit) for our pension and OPEB plans, including a mark-to-market (gain) loss, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash losses (gains) from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
Non-cash goodwill impairment charges. |
|
(8) |
The tax impact on the non-GAAP adjustments is affected by their tax deductibility and the applicable jurisdictional tax rates. |
|
(9) |
Receipt of cash related to the monthly settlement of our outstanding interest rate swap contracts. |
|
(10) |
The year ended December 31, 2023 includes cash received from the termination of our interest rate swap contracts. |
|
(11) |
In the second quarter of 2021, we incurred pre-tax Change in Control charges of |
|
(12) |
Reflects the portion of depreciation and amortization that is recognized in cost of goods sold. |
|
(13) |
Primarily reflects cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240212381431/en/
Michael Dillon
216-676-2000
investor.relations@graftech.com
Source: GrafTech International Ltd.
FAQ
What was GrafTech's net loss in Q4 2023?
What is the ticker symbol for GrafTech International Ltd.?
What cost rationalization and footprint optimization plans did GrafTech announce?
What are the key financial highlights for GrafTech in 2023?
How does GrafTech plan to address weak market conditions in 2024?